These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9215829

  • 1. Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy.
    Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, Meuli R, Gillet M, Lejeune F, Zografos L.
    J Clin Oncol; 1997 Jul; 15(7):2589-95. PubMed ID: 9215829
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma.
    Siegel R, Hauschild A, Kettelhack C, Kähler KC, Bembenek A, Schlag PM.
    Eur J Surg Oncol; 2007 Jun; 33(5):627-32. PubMed ID: 17196362
    [Abstract] [Full Text] [Related]

  • 3. Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
    Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD.
    Int J Clin Oncol; 2001 Feb; 6(1):25-8. PubMed ID: 11706523
    [Abstract] [Full Text] [Related]

  • 4. Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.
    Leyvraz S, Piperno-Neumann S, Suciu S, Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary T, Negrier S, Vermorken JB, Kaempgen E, Durando X, Schadendorf D, Gurunath RK, Keilholz U.
    Ann Oncol; 2014 Mar; 25(3):742-746. PubMed ID: 24510314
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients.
    Voelter V, Schalenbourg A, Pampallona S, Peters S, Halkic N, Denys A, Goitein G, Zografos L, Leyvraz S.
    Melanoma Res; 2008 Jun; 18(3):220-4. PubMed ID: 18477897
    [Abstract] [Full Text] [Related]

  • 6. Liver metastases from melanoma: hepatic intra-arterial chemotherapy. A retrospective study.
    Farolfi A, Ridolfi L, Guidoboni M, Milandri C, Calzolari F, Scarpi E, Amadori D, Ridolfi R.
    J Chemother; 2011 Oct; 23(5):300-5. PubMed ID: 22005064
    [Abstract] [Full Text] [Related]

  • 7. Treatment of disseminated ocular melanoma with sequential fotemustine, interferon alpha, and interleukin 2.
    Becker JC, Terheyden P, Kämpgen E, Wagner S, Neumann C, Schadendorf D, Steinmann A, Wittenberg G, Lieb W, Bröcker EB.
    Br J Cancer; 2002 Oct 07; 87(8):840-5. PubMed ID: 12373596
    [Abstract] [Full Text] [Related]

  • 8. Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patients.
    Peters S, Voelter V, Zografos L, Pampallona S, Popescu R, Gillet M, Bosshard W, Fiorentini G, Lotem M, Weitzen R, Keilholz U, Humblet Y, Piperno-Neumann S, Stupp R, Leyvraz S.
    Ann Oncol; 2006 Apr 07; 17(4):578-83. PubMed ID: 16469752
    [Abstract] [Full Text] [Related]

  • 9. [Hepatic intra-arterial bio-chemotherapy for the treatment of melanoma patients with liver metastasis: a phase II clinical study].
    Cui CL, Chi ZH, Yuan XQ, Lian HY, Si L, Guo J.
    Ai Zheng; 2008 Aug 07; 27(8):845-50. PubMed ID: 18710619
    [Abstract] [Full Text] [Related]

  • 10. Treatment of metastatic uveal melanoma with intravenous fotemustine.
    Spagnolo F, Grosso M, Picasso V, Tornari E, Pesce M, Queirolo P.
    Melanoma Res; 2013 Jun 07; 23(3):196-8. PubMed ID: 23624366
    [Abstract] [Full Text] [Related]

  • 11. Treatment of liver metastases from uveal melanoma by combined surgery-chemotherapy.
    Salmon RJ, Levy C, Plancher C, Dorval T, Desjardins L, Leyvraz S, Pouillart P, Schlienger P, Servois V, Asselain B.
    Eur J Surg Oncol; 1998 Apr 07; 24(2):127-30. PubMed ID: 9591028
    [Abstract] [Full Text] [Related]

  • 12. Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study.
    Khayat D, Cour V, Bizzari JP, Aigner K, Borel C, Cohen-Alloro G, Weil M, Auclerc G, Buthiau D, Bousquet JC.
    Am J Clin Oncol; 1991 Oct 07; 14(5):400-4. PubMed ID: 1951178
    [Abstract] [Full Text] [Related]

  • 13. Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study.
    Avril MF, Aamdal S, Grob JJ, Hauschild A, Mohr P, Bonerandi JJ, Weichenthal M, Neuber K, Bieber T, Gilde K, Guillem Porta V, Fra J, Bonneterre J, Saïag P, Kamanabrou D, Pehamberger H, Sufliarsky J, Gonzalez Larriba JL, Scherrer A, Menu Y.
    J Clin Oncol; 2004 Mar 15; 22(6):1118-25. PubMed ID: 15020614
    [Abstract] [Full Text] [Related]

  • 14. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC.
    Clin Cancer Res; 2000 Aug 15; 6(8):3062-70. PubMed ID: 10955785
    [Abstract] [Full Text] [Related]

  • 15. Fotemustine and interferon alpha2b in metastatic malignant melanoma.
    Weichenthal M, Mohr P, Stephan U, Altenhoff J, Kowalzick L, Marseille A, Sarkany M, Hossfeld DK, Breitbart EW.
    J Cancer Res Clin Oncol; 1998 Jan 15; 124(1):55-9. PubMed ID: 9498836
    [Abstract] [Full Text] [Related]

  • 16. Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options.
    Agarwala SS, Eggermont AM, O'Day S, Zager JS.
    Cancer; 2014 Mar 15; 120(6):781-9. PubMed ID: 24301420
    [Abstract] [Full Text] [Related]

  • 17. Fotemustine in the treatment of brain primary tumors and metastases.
    Khayat D, Giroux B, Berille J, Cour V, Gerard B, Sarkany M, Bertrand P, Bizzari JP.
    Cancer Invest; 1994 Mar 15; 12(4):414-20. PubMed ID: 8032964
    [Abstract] [Full Text] [Related]

  • 18. [Contribution of a new nitrosourea compound: fotemustine].
    Boaziz C.
    Pathol Biol (Paris); 1992 Dec 15; 40(9 Pt 2):964-8. PubMed ID: 1338920
    [Abstract] [Full Text] [Related]

  • 19. Initial experience with hepatic intraarterial fotemustine and interferon alpha 2b combination for treatment of liver tumors.
    Vitale FV, Romeo P, DI Maggio EM, Parisi A, Malaponte E, Calì S, Vasta F, Panebianco V, Arcoria D, Ferraù F.
    Anticancer Res; 2011 Dec 15; 31(12):4553-9. PubMed ID: 22199330
    [Abstract] [Full Text] [Related]

  • 20. Temozolomide in combination with fotemustine in patients with metastatic melanoma.
    Tas F, Camlica H, Topuz E.
    Cancer Chemother Pharmacol; 2008 Jul 15; 62(2):293-8. PubMed ID: 17909803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.